円形脱毛症の6歳から18歳未満の小児を対象としたバリシチニブ（LY3009104）の試験

基本情報

NCT ID

NCT05723198

ステータス

募集中

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

595

治験依頼者名

Eli Lilly and Company

概要

The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hair loss) in children from 6 years to less than 18 years of age. The study is divided into 4 periods, a 5-week Screening period, a 36-week Double-Blind Treatment Period, an approximately 2-year Long-term Extension Period, and a 4-week Post-treatment Follow-up period.

対象疾患

介入

依頼者（Sponsor）

実施施設 (8)